American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on Menopause–2017 Update
Tóm tắt
Từ khóa
Tài liệu tham khảo
Goodman, 2011, AACE medical guidelines for clinical practice for diagnosis and treatment of menopause, Endocr Pract, 17
Wharton, 2013, Rationale and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS cognitive and affective sub study (KEEPS Cog), Brain Res, 1514, 12, 10.1016/j.brainres.2013.04.011
NAMS 23rd Annual Meeting, Orlando, Florida, October 3–6, 2012. Available at: http://www.menopause.org/annual-meetings/2012-meeting/keeps-report. Accessed May 25, 2017.
Hodis, 2016, Vasuclar effects of early versus late postmenopausal treatment with estradiol, N Engl J Med, 374, 1221, 10.1056/NEJMoa1505241
Schierbeck, 2012, Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial, BMJ, 345, e6409, 10.1136/bmj.e6409
Rossouw, 2012, Study had insufficient power to investigate safety, BMJ, 345, e8146, 10.1136/bmj.e8146
Manson, 2013, Menopausal hormone therapy and health outcomes during the intervention and extended posts stopping phases of the Women's Health Initiative randomized trials, JAMA, 310, 1353, 10.1001/jama.2013.278040
Bassuk, 2014, Menopausal hormone therapy and cardiovascular disease risk: utility of biomarkers and clinical factors for risk stratification, Clin Chem, 60, 68, 10.1373/clinchem.2013.202556
Wild, 2013, Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials, Menopause, 20, 254, 10.1097/gme.0b013e31826f80e0
Wolff, 2013, Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS), Fertil Steril, 99, 1385, 10.1016/j.fertnstert.2012.11.053
Huang, 2009, Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women, Menopause, 16, 639, 10.1097/gme.0b013e31819c11e4
Thurston, 2016, Menopausal hot flashes and carotid intima media thickness among midlife women, Stroke, 47, 2910, 10.1161/STROKEAHA.116.014674
Crandall, 2017, Association of genetic variation in the tachykinin receptor 3 locus with hot flashes and night sweats in the Womens' Health Initiative Study, Menopause, 24, 252, 10.1097/GME.0000000000000763
Połać, 2013, Coagulation and fibrinolytic parameters in women and the effects of hormone therapy; comparison of transdermal and oral administration, Gynecol Endocrinol, 29, 165, 10.3109/09513590.2012.730567
Slater, 2001, Comparison of estrogen and androgen levels after oral estrogen replacement therapy, J Reprod Med, 46, 1052
L'Hermite, 2013, HRT optimization using transdermal estradiol plus micronized progesterone, a safer HRT, Climacteric, 16, 44, 10.3109/13697137.2013.808563
Canonico, 2008, Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis, BMJ, 336, 1227, 10.1136/bmj.39555.441944.BE
Sweetland, 2012, Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study, J Thromb Haemost, 10, 2277, 10.1111/j.1538-7836.2012.04919.x
Shufelt, 2014, Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study, Menopause, 21, 260, 10.1097/GME.0b013e31829a64f9
Renoux, 2010, Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study, BMJ, 340, c2519, 10.1136/bmj.c2519
Qureshi, 2016, Hormone replacement therapy and the risk of subarachnoid hemorrhage in postmenopausal women, J Neurosurg, 124, 45, 10.3171/2014.12.JNS142329
Fournier, 2008, Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer, J Clin Oncol, 26, 1260, 10.1200/JCO.2007.13.4338
Brinton, 2014, Breast cancer risk in older women: results from the NIH-AARP diet and health study, Cancer Causes Control, 25, 843, 10.1007/s10552-014-0385-3
Bourgain, 1990, Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure, Hum Reprod, 5, 537, 10.1093/oxfordjournals.humrep.a137138
Allen, 2010, Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition, Am J Epidemiol, 172, 1394, 10.1093/aje/kwq300
Biberoglu, 2016, Luteal phase support in intrauterine insemination cycles: a prospective randomized study of 300 mg versus 600 mg intravaginal progesterone tablet, Gynecol Endocrinol, 32, 55, 10.3109/09513590.2015.1077382
Fernández-Murga, 2012, Endometrial response to concurrent treatment with vaginal progesterone and transdermal estradiol, Climacteric, 15, 455, 10.3109/13697137.2011.644360
Furness, 2012, Hormone therapy in postmenopausal women and risk of endometrial hyperplasia, Cochrane Database Syst Rev, 8, CD000402
Canonico, 2010, Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study, Arterioscler Thromb Vasc Biol, 30, 340, 10.1161/ATVBAHA.109.196022
Stanczyk, 2015, Reprint of “Use of medroxyprogesterone acetate for hormone therapy in postmenopausal women: Is it safe?”, J Steroid Biochem Mol Biol, 153, 151, 10.1016/j.jsbmb.2015.08.013
Kerlikowske, 2003, Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population, J Clin Oncol, 21, 4314, 10.1200/JCO.2003.05.151
Collins, 2005, Breast cancer risk with postmenopausal hormonal treatment, Hum Reprod Update, 11, 545, 10.1093/humupd/dmi028
Fournier, 2005, Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort, Int J Cancer, 114, 448, 10.1002/ijc.20710
Stanczyk, 2013, Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects, Endocr Rev, 34, 171, 10.1210/er.2012-1008
Shao, 2012, Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study, Neurology, 79, 1846, 10.1212/WNL.0b013e318271f823
Stuenkel, 2017, Menopause hormone therapy and diabetes, Climacteric, 20, 11, 10.1080/13697137.2016.1267723
GalsonSK.Pharmacy Compounding/Compounding of Bio-identical Hormone Replacement Therapies. Available at: https://www.fda.gov/newsevents/testimony/ucm154031.htm. Accessed May 31, 2017.
Available at: http://www.fda.gov/forconsumers/byaudience/forwomen/ucm118624.htm.
Sharifi, 2014, Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy, Expert Rev Clin Pharmacol, 7, 281, 10.1586/17512433.2014.893819
Mirkin, 2013, Tissue-selective estrogen complexes for postmenopausal women, Maturitas, 76, 213, 10.1016/j.maturitas.2013.06.003
Rosen HN, Rosen CJ, Mulder JE.. Selective estrogen receptor modulators, Up to Date. 2017;.
Rietjens, 2017, The potential health effects of dietary phytoestrogens, Br J Pharmacol, 174, 1263, 10.1111/bph.13622
Guthrie, 2015, Pooled analysis of six pharmacologic and nonpharmacologic interventions for vasomotor symptoms, Obstet Gynecol, 126, 413, 10.1097/AOG.0000000000000927
Carroll, 2015, Critical appraisal of paroxetine for the treatment of vasomotor symptoms, Int J Womens Health, 7, 615, 10.2147/IJWH.S50804
Binkhorst, 2013, Unjustified prescribing of CYP2D6 inhibiting SSRIs in women treated with tamoxifen, Breast Cancer Res Treat, 139, 923, 10.1007/s10549-013-2585-z
Saadati, 2013, The effect of gabapentin on intensity and duration of hot flashes in postmenopausal women: a randomized controlled trial, Glob J Health Sci, 5, 126, 10.5539/gjhs.v5n6p126
Pinkerton, 2014, Phase 3 randomized controlled study of gastro-retentive gabapentin for the treatment of moderate-to-severe hot flashes in menopause, Menopause, 21, 567, 10.1097/GME.0b013e3182a7c073
Bordeleau, 2010, Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors, J Clin Oncol, 28, 5147, 10.1200/JCO.2010.29.9230
L'Espérance, 2013, Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors: CEPO review and recommendations, Support Care Cancer, 21, 1461, 10.1007/s00520-013-1732-8
Overk, 2008, High-content screening and mechanism-based evaluation of estrogenic botanical extracts, Comb Chem High Throughput Screen, 11, 283, 10.2174/138620708784246022
Gaube, 2007, Gene expression profiling reveals effects of Cimicifuga racemosa (L.) NUTT. (black cohosh) on the estrogen receptor positive human breast cancer cell line MCF-7, BMC Pharmacol, 7, 11, 10.1186/1471-2210-7-11
Mercado-Feliciano, 2012, An ethanolic extract of black cohosh causes hematological changes but not estrogenic effects in female rodents, Toxicol Appl Pharmacol, 263, 138, 10.1016/j.taap.2012.05.022
Bolle, 2007, Estrogen-like effect of a Cimicifuga racemosa extract sub-fraction as assessed by in vivo, ex vivo and in vitro assays, J Steroid Biochem Mol Biol, 107, 262, 10.1016/j.jsbmb.2007.03.044